EPOR & CD131 Heterodimer 蛋白|EPOR & CD131 Heterodimer protein|EPOR & CD131 Heterodimer(Human, Fc Tag)
- ￥4520
- Sino Biological
- CT010-H02H
- 2025年08月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 规格：
100 µg
蛋白名称：EPOR & CD131 Heterodimer蛋白, EPOR & CD131 Heterodimer protein
蛋白构建：A DNA sequence encoding the extracellular domain (Met 1-Pro 250) of human EPOR (NP_000112.1) linked with the extracellular domain (Trp 17-Trp 443) of human CD131 (NP_000386.1) by a peptide linker was fused with the Fc region of human IgG1 at the C-terminus.
表达宿主：HEK293 Cells
蛋白纯度：> 90 % as determined by SDS-PAGE
蛋白活性：1. Measured by its ability to bind rat EPO-His (Cat:80055-R08B) in a functional ELISA. 2. Measured by its ability to bind mouse EPO-His (Cat:51099-M08H) in a functional ELISA.
蛋白内毒素：< 1.0 EU per μg of the protein as determined by the LAL method
预测N端：Ala 25
蛋白分子量：The recombinant heterodimer of human EPOR & CD131 comprises 906 amino acids and has a calculated molecular mass of 101 kDa.
蛋白NP号：NP_000112.1 & NP_000386.1
蛋白氨基酸序列：Met1-Pro250 & Trp17-Trp443
蛋白标签：C-human IgG1-Fc
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验CD26 分子 CD26 常用单克隆抗体或代号： 5.9,Tal 主要表达细胞： Ta,Ba,Mac [NL] 分子质量(kDa)和结构： gp110 功 能： 二肽酰酶Ⅳ(DPPⅣ),HIV另一类受体,参与T细胞活化,腺苷脱氨酶结合蛋白 CD26 Aka dipeptidylpeptidase IV, adenosine deaminase complexing protein
Protein Expression and Purification of MBP-T antigen (131-259)
Comments: T antigen (131-259)is an MBP-Hisx6-fusion protein constructed by Laura Mizoue (refer to the wisdom page for details on the construct). i.Pick a single colony from freshly transformed cells (BL21 (DE3)is the expression host)into 2 ml of LB
Gene Therapy of X-Linked Severe Combined Immunodeficiency
to transduce ex vivo the CD34+cells of patients. This gene therapy protocol is currently being applied and the encouraging preliminary results published (1 ). The success of this protocol could be mainly attributed to the physiopathology of the SCID-X1 disease
技术资料暂无技术资料 索取技术资料
